Press Releases / Notices

The company’s press releases sometimes carry information on pharmaceutical drugs and products in the pipeline. Under no circumstances is such information provided to promote or advertise these products or offer medical advice.

NEWS 2026

October 01, 2026 Sustainability
  • SHARE
  • facebook
  • X

Establishment of the Nippon Shinyaku Medical Research Foundation

Kyoto, Japan, October 1, 2026 - Nippon Shinyaku Co., Ltd. (Head Headquarters, Kyoto; President, Toru Nakai; hereinafter “the Company”) hereby announced that it established the Nippon Shinyaku Medical Research Foundation (hereinafter “the Foundation”), a general incorporated foundation dedicated to promoting medical and pharmaceutical research, on October 1, 2026.
Guided by our business philosophy of “Helping People Lead Healthier, Happier Lives,” the Company has continued to provide research grants for young researchers.
The Foundation was established to further promote these initiatives in a sustainable and highly public-interest manner. Through the promotion of research in the fields of medicine and pharmacy and the development of the next generation of researchers, the Foundation aims to contribute to the improvement of people’s health and welfare. Going forward, the Company will contribute to the creation of outstanding research outcomes in the medical and pharmaceutical fields through the Foundation’s activities.

1. Purpose of the Foundation
To contribute to the improvement of people’s health and welfare by promoting research in medicine, pharmacy, and related fields, fostering researchers, and encouraging international exchange.

2. Overview of the Foundation
NameNippon Shinyaku Medical Research Foundation
Location14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, Japan
Date of establishmentOctober 1, 2026
Representative DirectorToru Nakai
Main activities

• Provision of grants to researchers active in the fields of medicine and pharmacy

• Other activities necessary to achieve the Foundation’s purpose

Officers at establishment
Councilors:
Tomoki Naoe, Makiko Osawa, Tsuneyo Mimori, Yusaku Okada, Keiichi Kuwano

Directors:
Masafumi Taniwaki, Shoichi Ishiura, Yoshiaki Okano, Isao Hara, Toru Nakai

Auditors:
Hiroaki Kinomoto, Kaori Hara

3. Research Grant Program
The Foundation plans to launch an open-call research grant program from FY2026, its first fiscal year. In FY2027, the Foundation will provide grants for research in the fields of hematological, muscular, pulmonary circulatory, and urological diseases, supporting innovative and pioneering research that contributes to the advancement of healthcare.

Contact
Public Relations & Investor Relations Dept., Nippon Shinyaku Co., Ltd.